The Innovation and Technology 2019/20 programme (under the Evidence Generation Fund), chose Patients Know Best (PKB) as an interoperable personal health record (PHR) tool and awarded funding for NHS organisations, covering the licence fee for deploying the service through its e-letters finance model.
As a certified B Corporation and social enterprise, PKB’s central mission is to empower patients with the information needed to better understand their health and care, along with the tools to increase self-care and independence whilst promoting prevention.
The e-letters model uses PKB as the vehicle to send digital correspondence to patients, enabling significant cost savings over traditional mail services, whilst also increasing patient activation and offering a wider approach to information sharing across borders using a digital patient-controlled, centralised PHR. The cash savings from patients engaging with digital rather than postal letters finances the PHR roll-out.
Dr Mohammad Al-Ubaydli, CEO and founder of PKB said: “NHS England has only allocated this funding to one PHR, which is a big endorsement of the achievements of our existing PKB customers. It is great that NHS England are pump-priming new healthcare organisations in their digital roadmaps for delivering a patient portal. It also supports our mission as a social enterprise to empower patients to take control. We’re thrilled as this helps us to bring more data, more quickly to more patients.”
As the only true patient portal and the most deployed PHR in the UK, patients offered access to their personal health records with PKB will immediately see the benefits. They will no longer need to wait for appointment letters in the post, call the hospital to follow up on their test results, or worry anxiously about the information they may have forgotten during their last appointment. This information will be available in their PKB record along with other vital data including their personalised care plans, medications and diagnosis information, along with the ability to remotely share this data in real-time as clinically required.
For more information, or to discuss this opportunity for your organisation or partnership, email email@example.com.